Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tryptophan Challenge in Schizophrenia
NCT02067975Phase 3Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Aug 2014
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Change in Verbal Memory Scores. Started Aug 2014; status: completed.
Beyond the preview
Go deeper on NCT02067975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02067975.